Skip to content

A multicentre, prospective, randomised, controlled study evaluating the efficacy of single-use electric snare incision devices in super-minimally invasive resection of submucosal tumours of the stomach

A multicentre, prospective, randomised, controlled study evaluating the efficacy of single-use electric snare incision devices in super-minimally invasive resection of submucosal tumours of the stomach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120899
Enrollment
Unknown
Registered
2026-03-22
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumour of the stomach

Interventions

Conventional SMIS Surgery Group:Conventional SMIS surgery (using standard multi-instrument mode)
All In One Electrosurgical Loop Knife SMIS Group:SMIS surgery using All In One single-use electrosurgical loop knife

Sponsors

The First Medical Centre of the PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and < 80 years, without restriction on gender. 2. Gastric gastrointestinal stromal tumour <= 1.5 cm. 3. Meeting surgical indications for SMIS. 4. Normal preoperative coagulation function, complete blood count, and biochemical parameters. 5. Absence of surgical contraindications. 6. Patient and family members understand the study protocol, voluntarily participate in this research, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participation in other clinical studies within the four weeks preceding enrolment in this study 2. Pregnant or lactating women, or female patients planning pregnancy during the study period 3. Subjects with poor physical condition due to severe cardiovascular disease, or other serious respiratory, haematological, hepatic, renal, or gastrointestinal disorders (e.g., Crohn's disease, ulcerative colitis) 4. Any of the following abnormal laboratory findings at screening: (1) AST or ALT > 2 times the upper limit of normal (ULN) (2) Total bilirubin > 2 times ULN (3) Creatinine > 2 times ULN 5. Electrocardiogram (ECG) abnormalities including: severe arrhythmia, multifocal ventricular premature contractions (PVCs), second-degree or higher atrioventricular block 6. History of upper gastrointestinal resection 7. Any other reason deemed by the investigator to render the subject unsuitable for participation in this study

Design outcomes

Primary

MeasureTime frame
En bloc resection rate;R0 resection rate;Total operative time;Core resection time;

Secondary

MeasureTime frame
Postoperative hospital stay duration;

Countries

China

Contacts

Public ContactLinghu Enqiang

The First Medical Centre of the PLA General Hospital

linghuenqiang@vip.sina.com+86 156 2082 2739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026